Duovent 0.5 mg - 1.25 mg/4 ml nebul. sol. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

duovent 0.5 mg - 1.25 mg/4 ml nebul. sol. vial

boehringer ingelheim scomm-commv - ipratropium bromide monohydrate 0,522 mg - eq. ipratropium bromide anhydrous 0,5 mg; fenoterol hydrobromide 1,25 mg - nebuliser solution - 0,5 mg/4 ml - 1,25 mg/4 ml - fenoterol hydrobromide 1.25 mg; ipratropium bromide monohydrate 0.522 mg - fenoterol and ipratropium bromide

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

ZERSEOS Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos

cipla (eu) limited - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram - salbutamol and sodium cromoglicate

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution Ireland - English - HPRA (Health Products Regulatory Authority)

zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution

azure pharmaceuticals ltd - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Duovent Nebuliser solution in Unit Dose Vial 4ml Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duovent nebuliser solution in unit dose vial 4ml

boehringer ingelheim (malaysia) sdn. bhd. - ipratropium bromide monohydrate; fenoterol hydrobromide -

Combivent New Zealand - English - Medsafe (Medicines Safety Authority)

combivent

boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 21ug; salbutamol sulfate 120ug - aerosol inhaler, metered dose - 120µg/21µg per dose - active: ipratropium bromide monohydrate 21ug salbutamol sulfate 120ug excipient: dichlorodifluoromethane lecithin trichlorofluoromethane

COMBIVENT UNIT DOSE VIAL FOR INHALATION Singapore - English - HSA (Health Sciences Authority)

combivent unit dose vial for inhalation

boehringer ingelheim singapore pte. ltd. - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol - solution - 0.5 mg/2.5 ml - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous 0.5 mg/2.5 ml; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol 2.500 mg/2.5 ml

Atrovent New Zealand - English - Medsafe (Medicines Safety Authority)

atrovent

boehringer ingelheim (nz) ltd - ipratropium bromide monohydrate 0.0042 g equivalent to 0.0040 g anhydrous, per container - aerosol inhaler, metered dose - 20 mcg/dose - active: ipratropium bromide monohydrate 0.0042 g equivalent to 0.0040 g anhydrous, per container excipient: cryofluorane dichlorodifluoromethane lecithin trichlorofluoromethane

Duolin New Zealand - English - Medsafe (Medicines Safety Authority)

duolin

rex medical ltd - ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose; salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose - solution for inhalation - 500µg/2.5mg per dose - active: ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose excipient: purified water sodium chloride sulfuric acid - duolin is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.

Univent New Zealand - English - Medsafe (Medicines Safety Authority)

univent

rex medical ltd - ipratropium bromide monohydrate 0.25 mg/ml - solution for inhalation - 0.5 mg/2ml - active: ipratropium bromide monohydrate 0.25 mg/ml excipient: hydrochloric acid sodium chloride water for injection - for the short term acute treatment of the reversible component in chronic obstructive airways disease, such as chronic bronchitis and bronchial asthma.